Case Report: Exceptional Response to Poziotinib in Patient with Metastatic Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutation

Prelaj, A; Bottiglieri, A; Bhat, G; Washington, R; Calareso, G; Greco, GF; Ferrara, R; Brambilla, M; De Toma, A; Occhipinti, M; Manglaviti, S; Soro, A; Ganzinelli, M; Lo Russo, G; Proto, C

Bottiglieri, A (通讯作者)，Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

Among the several next-generation tyrosine kinase inhibitors (TKIs) tested against uncommon EFGR alterations, poziotinib has been demonstrated to be a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索